7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 
      
                    
      assets
                    
      current assets:
                    
      cash and cash equivalents
    79,005,000 62,336,000 80,861,000 105,679,000 161,846,000 100,025,000 154,574,000 394,583,000 126,119,000 303,665,000 274,892,000 64,179,000 56,763,000 164,540,000 127,160,000 30,833,000 
      marketable securities
    382,378,000 390,767,000 462,404,000 481,696,000 412,408,000 416,663,000 419,345,000 307,434,000 313,597,000 202,819,000 258,701,000 190,656,000 224,018,000 142,446,000 83,769,000 73,784,000 
      restricted cash, current
      208,000 208,000 208,000 208,000 208,000 1,903,000         
      prepaid expenses and other current assets
    10,698,000 10,792,000 10,681,000 11,727,000 12,839,000 13,307,000 14,606,000 12,443,000 20,260,000 22,155,000 16,544,000 12,028,000 9,524,000 18,761,000 9,974,000 8,192,000 
      total current assets
    472,081,000 463,895,000 554,154,000 599,310,000 587,301,000 530,203,000 588,733,000 716,363,000 491,456,000 558,070,000 571,367,000 266,863,000 290,305,000 325,747,000 220,903,000 112,809,000 
      restricted cash, non-current
    2,616,000 2,418,000 2,418,000 2,418,000 2,418,000 2,418,000 2,418,000 2,418,000         
      marketable securities, non-current
    114,591,000 84,502,000 21,942,000 38,277,000 102,428,000 130,128,000 117,102,000 27,168,000         
      property and equipment
    43,076,000 44,472,000 45,568,000 46,456,000 47,497,000 46,276,000 44,930,000 42,728,000 37,782,000 22,285,000 14,421,000 11,231,000 10,034,000 9,660,000 10,127,000 10,318,000 
      operating lease right-of-use assets
    23,225,000 23,416,000 23,603,000 23,789,000 23,934,000 24,065,000 24,196,000 27,099,000 29,142,000 29,386,000 29,645,000 28,659,000 28,969,000 27,449,000 3,248,000  
      prepaid research and development expenses and other long-term assets
    329,000 383,000 397,000 1,077,000 1,331,000 1,216,000 2,316,000 9,356,000 7,949,000 11,286,000 5,009,000 4,563,000 5,518,000 9,969,000 8,913,000  
      total assets
    655,918,000 619,086,000 648,082,000 711,327,000 764,909,000 734,306,000 779,695,000 825,132,000 614,218,000 623,528,000 622,943,000 313,817,000 337,327,000 375,326,000 243,390,000 128,782,000 
      liabilities and stockholders’ equity
                    
      current liabilities:
                    
      accounts payable
    4,204,000 2,079,000 4,369,000 2,095,000 5,989,000 4,868,000 3,099,000 2,619,000 7,185,000 5,693,000 4,532,000 9,053,000 2,962,000 7,556,000 1,874,000 1,333,000 
      accrued liabilities
    46,967,000 53,034,000 43,359,000 56,716,000 43,038,000 42,033,000 33,933,000 18,302,000 16,916,000 12,390,000 13,997,000 11,679,000 11,212,000 22,059,000 14,400,000 13,180,000 
      operating lease liabilities, current portion
    7,471,000 7,416,000 7,361,000 7,308,000 7,253,000 7,199,000 7,146,000 7,501,000 6,582,000 6,111,000 4,947,000 2,901,000 2,874,000 2,313,000 370,000  
      finance lease liabilities, current portion
       230,000 10,865,000 19,220,000 32,531,000 39,283,000 48,286,000 38,045,000 35,294,000 33,060,000 27,729,000    
      contract liability to related party
    59,750,000 59,321,000 57,372,000 59,056,000 69,872,000 14,970,000 31,192,000 50,533,000         
      total current liabilities
    118,392,000 121,850,000 112,461,000 125,405,000 137,017,000 88,290,000 107,901,000 118,238,000 173,149,000 156,114,000 166,057,000 56,693,000 44,777,000 32,053,000 16,808,000 14,845,000 
      operating lease liabilities, net of current portion
    44,323,000 45,097,000 45,831,000 46,542,000 47,214,000 47,872,000 47,685,000 50,841,000 48,096,000 40,638,000 31,994,000 31,299,000 29,212,000 27,200,000 4,844,000  
      contract liability to related party, net of current portion
    52,426,000 59,916,000 69,447,000  82,612,000 96,081,000           
      other non-current liabilities
      3,437,000 8,593,000 15,048,000 14,899,000 15,468,000          
      total liabilities
    215,141,000 226,863,000 231,176,000 256,535,000 281,891,000 247,142,000 283,122,000 339,752,000 348,090,000 329,861,000 319,226,000 108,863,000 101,043,000 59,370,000 21,799,000 16,918,000 
      commitments and contingencies
                    
      stockholders’ equity
                    
      common stock
    56,000 54,000 54,000 53,000 53,000 53,000 53,000 52,000 48,000 48,000 48,000 44,000 44,000 44,000 36,000 1,000 
      additional paid-in capital
    1,107,665,000 1,003,635,000 975,301,000 950,719,000 930,813,000 911,783,000 893,710,000 874,261,000 675,469,000 663,614,000 649,717,000 523,921,000 516,437,000 510,761,000 384,095,000 8,615,000 
      accumulated other comprehensive income
    706,000 403,000 649,000 848,000 1,899,000 -792,000 -512,000 547,000   86,000      
      accumulated deficit
    -667,650,000 -611,869,000 -559,098,000 -496,828,000 -449,747,000 -423,880,000 -396,678,000 -389,480,000 -409,324,000 -369,988,000 -346,134,000 -318,790,000 -279,798,000 -194,587,000 -162,496,000 -130,111,000 
      total stockholders’ equity
    440,777,000 392,223,000 416,906,000 454,792,000 483,018,000 487,164,000 496,573,000 485,380,000 266,128,000 293,667,000 303,717,000 204,954,000 236,284,000 315,956,000 221,591,000  
      total liabilities and stockholders’ equity
    655,918,000 619,086,000 648,082,000 711,327,000 764,909,000 734,306,000 779,695,000 825,132,000 614,218,000 623,528,000 622,943,000      
      contract liabilities, net of current portion to related party
       75,995,000    170,673,000         
      stockholders’ equity:
                    
      contract liability, net of current portion to related party
          112,068,000          
      finance lease liabilities, net of current portion
            5,755,000 8,841,000 15,413,000 20,871,000 27,054,000    
      receivable from collaboration partner
            31,480,000 29,431,000 21,230,000      
      restricted cash
            4,929,000 2,501,000 2,501,000 2,501,000 2,501,000 2,501,000 199,000 199,000 
      marketable securities non current
            42,960,000        
      contract liability
            94,180,000 93,875,000 107,287,000      
      contract liability, net of current portion
            121,090,000 124,268,000 105,762,000      
      preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of september 30, 2023 or december 31, 2022
                    
      accumulated other comprehensive loss
            -65,000 -7,000  -221,000 -399,000 -262,000 -44,000 -20,000 
      preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of june 30, 2023 or december 31, 2022
                    
      preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of march 31, 2023 or december 31, 2022
                    
      deferred offering costs
                   3,172,000 
      liabilities, redeemable convertible preferred stock, and stockholders’ equity
                    
      deferred rent, current portion
                   183,000 
      other current liabilities
                 125,000 164,000 149,000 
      deferred rent, net of current portion
                   1,895,000 
      other long-term liabilities
                 117,000 147,000 178,000 
      redeemable convertible preferred stock
                    
      series a redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of december 31, 2022; 29,795,227 shares authorized and 5,413,272 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 29,795 as of december 31, 2022 and december 31, 2021, respectively
                    
      series b redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of december 31, 2022; 49,402,623 shares authorized and 8,975,585 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 85,681 as of december 31, 2022 and december 31, 2021, respectively
                    
      series c redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of december 31, 2022; 57,224,618 shares authorized and 10,396,707 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 120,000 as of december 31, 2022 and december 31, 2021, respectively
                    
      total redeemable convertible preferred stock
                   233,379,000 
      preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of december 31, 2022; no shares authorized, issued or outstanding as of december 31, 2021
                    
      total liabilities, redeemable convertible preferred stock, and stockholders’ equity
               313,817,000 337,327,000 375,326,000 243,390,000  
      series a redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of september 30, 2022; 29,795,227 shares authorized and 5,413,272 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 29,795 as of september 30, 2022 and december 31, 2021, respectively
                    
      series b redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of september 30, 2022; 49,402,623 shares authorized and 8,975,585 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 85,681 as of september 30, 2022 and december 31, 2021, respectively
                    
      series c redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of september 30, 2022; 57,224,618 shares authorized and 10,396,707 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 120,000 as of september 30, 2022 and december 31, 2021, respectively
                    
      preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of september 30, 2022; no shares authorized, issued or outstanding as of december 31, 2021
                    
      series a redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of june 30, 2022; 29,795,227 shares authorized and 5,413,272 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 29,795 as of june 30, 2022 and december 31, 2021, respectively
                    
      series b redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of june 30, 2022; 49,402,623 shares authorized and 8,975,585 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 85,681 as of june 30, 2022 and december 31, 2021, respectively
                    
      series c redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of june 30, 2022; 57,224,618 shares authorized and 10,396,707 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 120,000 as of june 30, 2022 and december 31, 2021, respectively
                    
      preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of june 30, 2022; no shares authorized, issued or outstanding as of december 31, 2021
                    
      series a redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of march 31, 2022; 29,795,227 shares authorized and 5,413,272 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 29,795 as of march 31, 2022 and december 31, 2021, respectively
                    
      series b redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of march 31, 2022; 49,402,623 shares authorized and 8,975,585 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 85,681 as of march 31, 2022 and december 31, 2021, respectively
                    
      series c redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of march 31, 2022; 57,224,618 shares authorized and 10,396,707 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 120,000 as of march 31, 2022 and december 31, 2021, respectively
                    
      preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of march 31, 2022; no shares authorized, issued or outstanding as of december 31, 2021
                    
      other long-term assets
                   2,284,000 
      liabilities, redeemable convertible preferred stock, and stockholders’ deficit
                    
      series a redeemable convertible preferred stock, par value of 0.001 per share; 29,795,227 shares authorized at december 31, 2021 and 2020; 5,413,272 shares issued and outstanding at december 31, 2021 and 2020; liquidation value 29,795 at december 31, 2021 and 2020.
                   28,894,000 
      series b redeemable convertible preferred stock, par value 0.001 per share; 49,402,623 shares authorized at december 31, 2021 and 2020; 8,975,585 shares issued and outstanding at december 31, 2021 and 2020; liquidation value of 85,681 at december 31, 2021 and 2020.
                   85,367,000 
      series c redeemable convertible preferred stock, par value 0.001 per share; 57,224,618 shares and 0 authorized at december 31, 2021 and 2020, respectively; 10,396,707 and 0 shares issued and outstanding at december 31, 2021 and 2020, respectively; liquidation value of 120,000 and 0 at december 31, 2021 and 2020, respectively.
                   119,118,000 
      stockholders’ deficit:
                    
      total stockholders’ deficit
                   -121,515,000 
      total liabilities, redeemable convertible preferred stock, and stockholders’ deficit
                   128,782,000 
      revenue
                    
      operating expenses:
                    
      research and development
                   46,883,000 
      general and administrative
                   18,135,000 
      total operating expenses
                   65,018,000 
      income from operations
                   -65,018,000 
      other income
                   49,000 
      net income
                   -64,969,000 
      other comprehensive loss:
                    
      unrealized loss on marketable securities
                   20,000 
      comprehensive loss
                   -64,989,000 
      net income per share
                   -145,550 
      weighted-average common shares outstanding—basic and diluted
                   446,379,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.